ESPR Abstract Submission Portal

INSTRUCTIONS FOR SUBMITTING AN ABSTRACT FOR ESPR MEETING 2024

Deadline for submissions: Friday, November 17, 2023 at 11:59pm eastern.

The ESPR Program Committee is committed to presenting the broadest possible range of high-quality work at the ESPR Meeting. All submitters should go to the ESPR Abstract Submission Site, create a new account and follow instructions to submit your abstract.

Historically, abstracts accepted for presentation are hypothesis-driven new work. Abstracts rarely accepted for presentation include open-label drug trials, single case reports, highly speculative accounts of clinical experience, and op-ed accounts of personal experience. Interim results from an ongoing clinical trial will not be accepted for presentation unless the study has been prematurely closed for efficacy, lack of efficacy, or issues of safety. The submission of multiple, similar abstracts from the same investigator(s) or laboratory are strongly discouraged.

TABLE OF CONTENTS:

1. Abstract Selection Process
2. Award Consideration and Selection
3. Publication of Abstracts
4. General Submission Policies
5. Abstract Submission Fee(s)
6. Notification of Receipt and Acceptance

1. ABSTRACT SELECTION PROCESS

Abstracts of superior quality will be selected for presentation and will be graded based on quality of scientific merit/importance, research design, data analysis and presentation. The submission of abstracts with incomplete data or analyses will be evaluated only based on the information provided.

2. AWARD CONSIDERATION AND SELECTION

ESPR seeks nominations for awards through the abstract submission process. Information regarding the awards, their eligibility criteria, and the award process can be found on the Awards page. Only abstracts accepted for presentation are considered for awards.

Procedures

Application for an award involves completing all of the following electronically by the submission deadline:

1. Submitting an abstract electronically

2. Clicking the appropriate button in the "Awards " part of the submission program.

3. Uploading the required supplemental materials (as indicated in the award information and on the Application Form).

You are welcome to apply for more than one award.

ESPR Young Investigator awards

1. Faculty

First author presenters who are junior faculty (<10 years out of completion of training) are eligible to apply for Faculty Young investigator awards. The highest ranked 3 abstracts will be selected for this session. Each award covers the cost of one PAS registration at the faculty registration rate.

2. Trainee

First author presenters who are currently in training are eligible to apply for Trainee Young investigator awards. The highest ranked 3 abstracts will be selected for this session.

ESPR Trainee Travel Award

Travel awards will be available for first-author presenters who are currently in training. Awards will be made based on the scientific merits of the abstracts and the availability of sufficient funds. These awards provide 1 night hotel accommodations for eligible first-authors-in-training.

ESPR Diversity in the Research Workforce Travel Awards

ESPR is sponsoring two persons (one Trainee and one Faculty) for the Diversity in the Research Workforce Travel Awards. The purpose of the Diversity in the Research Workforce Travel Awards is to promote diversity and inclusion within the research workforce and support the travel of gifted young scientists of an “under-represented” background to their annual meetings.

• The Awardees must be deserving from a scientific perspective and demonstrate commitment to Pediatric Research.
• The Awardee must also be of an “under-represented” background as defined by the NIH.
• Applications will only be considered from trainees of all levels and from faculty who have finished residency or fellowship in the last 3 years (e.g., since 2020).

Required documents:

• A Letter of Nomination by a dues-paying member of ESPR briefly outlining the reasons for the nomination.
• A current NIH-format Biosketch with the Personal Statement describing the scientific merit of the applicant's work, the applicant's "under-represented" background and their career stage and trajectory.

Candidates for ALL awards must fulfill the following conditions:

• Check the appropriate box in the ESPR abstract submission program and provide documentation of trainee status, if selecting “trainee awards” as well as documentation of underrepresented background and nomination letter for diversity awards.
• Currently practicing or training in the ESPR area.
• First authorship (presenting author) on an abstract submitted to the Eastern SPR Scientific Meeting.
• The awardee must present the study at the Eastern SPR Annual Meeting.
• Abstract and supplemental materials must be received by the ESPR abstract submission deadline.
• Please note: one presenter cannot select both trainee and faculty award.

ESPR Presentation Formats

Presentation formats (platform or poster) are determined in February by the ESPR Program Committee. Platform sessions are 1.5-2 hours in length. Presentations are 15-minutes (10 minute/presentation; 5 minute/discussion).

Poster sessions are 1.5-3 hours in length and consist of a general viewing and author attendance period. Detailed instructions for the preparation of slides and posters as well as scheduling notices will be provided to the contact author with the presentation notification in February. Platform and poster guidelines will be available on the official ESPR Meeting website. The complete schedule of all abstract presentations will be finalized by early February.

3. PUBLICATION OF ABSTRACTS

ALL abstracts, if accepted for presentation, will be viewable online.

4. GENERAL SUBMISSION POLICIES

• Character count is 3000.
• Able to submit to multiple societies as long as abstract is not published.
• A submission fee is required for each abstract submitted. Submission fees are listed on abstract submission page.
• Sponsorship is NOT required to submit an abstract for the ESPR Meeting.
• There is no limit on the number of abstracts submitted by each author, but the submission of multiple, similar abstracts from the same investigator(s) or laboratory is strongly discouraged.
• Abstracts submitted for other national meetings can be submitted for consideration. Abstracts already presented to other societies or national meetings cannot be submitted for consideration unless additional data has been added.
• Research published in manuscript form prior to the submission of the abstract is not appropriate and should not be submitted. If data contained in the abstract is published after submission of the abstract, the ESPR Program Office must be notified regardless of timing as soon as publication is recognized. At that time a member of the program committee will make a determination concerning presentation. Abstracts should not be submitted if there is knowledge and confirmation of an upcoming publication prior to the annual meeting or submission deadline.

Case submission (Only Trainees eligible as first author):

Include the following headings:

• History (including the chief complaint, history of present illness, and relevant past medical and family history). Please include only information relevant to the evaluation or final diagnosis.
• Physical Examination: Vital signs, pertinent physical examination findings.
• Laboratory testing and/or diagnostic imaging
• Final Diagnosis
• Discussion
• Optional: Up to two digital images or radiographs without interpretation.

Conflict of Interest/ Disclosure: Work submitted for presentation must include an acknowledgment of funding sources of commercial nature and/or consulting or holding of significant equity in a company that could be affected by the results of the study. Even if indicated elsewhere in the abstract, this must appear as the last sentence of the abstract and read "funded by..." and/or "equity in..." if pertinent.

Any animal studies must conform with the "Guiding Principles in the Care and Use of Animals" of the American Physiological Society and any human experimentation has been conducted according to a protocol approved by the institutional committee on ethics of human investigation. And, if no such committee exists, that it conforms with the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 14: 193, 1966).

First author is presumed to be the presenting author. Please verify all co-author information including email IDs are accurate and up to date.

The submitting author verifies upon submission that All Authors have agreed to the submission of the abstract.

If the abstract is selected, the presentation must include the methods used for study and any other information relevant to research.

Reviewer scores and comments are confidential and are not available to anyone (including authors) outside of the review process.

The decision of the Program Committee to accept or decline an abstract is final. The decision on which format the abstract will be presented is also the decision of the Program Committee.

5. ABSTRACT AND CLINICAL CASE SUBMISSION FEES

The submission fees for abstracts and clinical cases listed on the abstract submission site must be made directly online by credit card.

6. NOTIFICATION OF RECEIPT AND ACCEPTANCE

Notification of receipt will be automatically emailed to the contact author upon submission of the abstract.

Notification of abstract acceptance status will be emailed to the contact author listed on the abstract in February. Note that the security firewall at some institutions may block communications from ESPR. You can log into your ESPR abstract account at any point to check for emails and invitations to present.

If you have questions, please contact the ESPR Program Office at info@eastern-spr.org for additional assistance.